Neurotech saw $2.3B in investments in 2024. Some key takeaways:
• Implanted tech secured more funding despite fewer deals
• Pain, Parkinson’s, and Depression were the top-funded conditions
• 7 companies raised over $100M each
• The sector grew at an impressive 90% annual rate